Abstract
Background
Diagnostic imaging and biopsy are used to evaluate abnormal screening mammography. Differences in on-site availability and receipt of these diagnostic services may contribute to disparities in breast cancer outcomes across sociodemographic groups.
Purpose
To identify multilevel factors associated with on-site availability and receipt of diagnostic imaging and biopsy after screening mammography.
Materials and Methods
This retrospective study included female patients (age range, 40–89 years) who underwent screening mammography at 136 facilities in the United States from January 2010 to December 2020. The primary exposure variables were race and ethnicity and neighborhood-level educational attainment, household income, and rurality. The adjustment variables were age, breast density, breast biopsy history, personal and family history of breast cancer, time from prior mammographic examination to screening mammography, screening modality, facility academic affiliation, and screening examination year. The relative risk (RR) of factors for on-site availability at screening facilities and undergoing standard-of-care imaging (ie, mammography and/or US) and advanced diagnostic imaging (ie, digital breast tomosynthesis, MRI) and biopsy, and undergoing any same-day diagnostic service and biopsy were estimated using modified Poisson regression.
Results
In total, 1 123 177 female patients (median age, 59 years; IQR, 51–67 years) underwent 3 519 502 screening mammographic examinations: 10.3% Asian patients (362 440 of 3 519 502), 12.7% Black patients (447 777 of 3 519 502), 6.5% Hispanic patients (227 177 of 3 519 502), 68.3% White patients (2 403 159 of 3 519 502), and 2.2% all other races and ethnicities (78 949 of 3 519 502). In most fully adjusted models, race or ethnicity and neighborhood-level socioeconomic status were not associated with on-site diagnostic service availability. However, compared with White patients, patients belonging to racial and ethnic minority groups were less likely to undergo same-day diagnostic services after abnormal screening mammography (Asian patients: RR, 0.74 [95% CI: 0.64, 0.85]; Black patients: RR, 0.56 [95% CI: 0.49, 0.63]; Hispanic patients: RR, 0.61 [95% CI: 0.52, 0.71]). Black patients were less likely to undergo same-day biopsies after an abnormal diagnostic workup (RR, 0.46; 95% CI: 0.33, 0.65).
Conclusion
Although no evidence existed that on-site diagnostic service availability varied by race and ethnicity in most models, patients in racial and ethnic minority groups were less likely to be provided same-day diagnostic services and Black patients were less likely to undergo same-day biopsy.
© RSNA, 2025
Supplemental material is available for this article.
See also the editorial by Mullen in this issue.
Summary
Despite similar on-site availability, differences existed in the distribution of some standard-of-care, advanced, and same-day diagnostic services and biopsies for Black and White patients after undergoing screening mammography.
Key Results
■ In a retrospective study of 1 123 177 patients who underwent 3 519 502 screening mammographic examinations, on-site availability of most diagnostic services was similar across race and ethnicity groups, but patients in racial and ethnic minority groups were less likely to undergo standard-of-care diagnostic imaging after abnormal screening compared with White patients (eg, Black patients: relative risk [RR], 0.93; P < .001).
■ After multilevel adjustment, Black patients were less likely than White patients to undergo a same-day diagnostic evaluation after abnormal screening mammography (RR, 0.56; P < .001) or same-day biopsy after a biopsy recommendation (RR, 0.46; P < .001).
Introduction
Screening mammography is an important first step in early breast cancer detection and treatment and can help reduce breast cancer mortality (1). After abnormal screening mammography, additional imaging and possibly image-guided biopsy are recommended for completion of the screening episode of care (2,3). However, not all facilities offering screening mammography provide all the diagnostic services (ie, imaging and image-guided biopsy) required for a complete workup. This lack of on-site availability of diagnostic services may be an obstacle to timely, definitive breast cancer diagnosis and may lead to delayed treatment (4).
Populations with higher breast cancer mortality—Black patients, patients with lower income or lower educational attainment, and patients living in rural regions—often face lower availability of breast imaging technologies within their residential geographic regions or at screening sites they attend (5–9). Furthermore, few facilities provide individuals with appointments for diagnostic imaging or image-guided biopsy (hereafter, biopsy) on the same day of screening or diagnostic examinations, respectively. Same-day appointments can reduce the time to diagnostic resolution and, potentially, disparities in breast cancer outcomes (10,11).
The availability of diagnostic breast imaging and biopsy services at the screening facility attended by an individual can be related to individual-, neighborhood-, and health care system–level factors. Understanding the differences in the availability and receipt of diagnostic breast services between populations and the factors associated with these differences may help guide the development of interventions to reduce disparities in breast cancer care and outcomes.
The purpose of this study was to identify the multilevel factors associated with availability of and patients undergoing standard-of-care and advanced diagnostic services, including same-day diagnostic services, after abnormal screening mammography.
Materials and Methods
Study Setting, Data Sources, and Patients
This retrospective study involved data from the following six Breast Cancer Surveillance Consortium breast imaging registries (www.bcsc-research.org): Carolina Mammography Registry, Kaiser Permanente Washington Registry, Metro Chicago Breast Cancer Registry, New Hampshire Mammography Network, San Francisco Mammography Registry, and the Vermont Breast Cancer Surveillance System. The data are pooled at the Breast Cancer Surveillance Consortium Statistical Coordinating Center. Each registry and the Statistical Coordinating Center have received institutional review board approval for all study procedures, including informed consent, passive permission, or a waiver of informed consent to enroll patients, link data, and perform analytic studies. All protocols were Health Insurance Portability and Accountability Act compliant, and the identities of individuals, physicians, and facilities were protected by a Federal Certificate of Confidentiality and other protections.
Digital mammography and digital breast tomosynthesis (DBT) examinations with a screening indication were included if they were performed at a registry facility from January 2010 to December 2020 on female patients (age range, 40–89 years) who lived within the cancer registry catchment areas. Examinations performed at facilities with fewer than 100 screening examinations during the study period and those with missing data for variables of interest were excluded. To evaluate whether diagnostic technologies were used, the data for abnormal screening mammographic examinations with Breast Imaging Reporting and Data System assessment categories 0, 3, 4, or 5, which is consistent with the ACR BI-RADS Atlas (12), and those performed at facilities with on-site availability of the technology being evaluated were included. However, examinations performed at facilities with less than 75% biopsy capture and examinations with fewer than 90 days of follow-up imaging or pathologic analysis were excluded. To evaluate whether same-day biopsy was performed, the first abnormal diagnostic mammographic or breast US examination completed after the abnormal screening mammographic examination with Breast Imaging Reporting and Data System assessment category 4 or 5, indicating a recommendation for biopsy, was considered (12). The evaluation of patients undergoing same-day biopsy was limited to examinations performed within facilities offering biopsy services. This study was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines (13).
Measures, Definitions, and Outcomes
The primary exposure variables of interest were race and ethnicity and neighborhood-level socioeconomic factors. Individuals’ self-reported race and ethnicity were categorized as non-Hispanic Asian (hereafter, Asian); non-Hispanic Black or African American (hereafter, Black); Hispanic or Latinx; non-Hispanic White (hereafter, White); or all other races and ethnicities, including Alaska Native, American Indian, Native Hawaiian, Pacific Islander, multiple races (two or more races), or other races and ethnicities. The residential five-digit zip codes of patients were linked to the 2007–2011 American Community Survey data to obtain neighborhood-level high school educational attainment and median household income and to the 2010 Rural Urban Commuting Area codes for residential rurality (Appendix S1) (14–16).
Individual-level factors obtained at the time of screening mammography from questionnaires or the electronic health records included age, Breast Imaging Reporting and Data System breast density, history of breast biopsy, personal and first-degree family history of breast cancer, and time since last mammographic examination. Health care system–level factors included screening mammographic modality (ie, digital mammography or DBT, which was approved by the U.S. Food and Drug Administration in 2011 during the early years of the study period) (9) and screening facility academic affiliation. Individual-level factors were deemed nonmodifiable or not easily modified (eg, age, family and personal history of breast cancer, history of breast biopsy, and breast density) or modifiable (eg, time since last mammographic examination) if the factor could be changed with an intervention.
The availability of standard-of-care or advanced diagnostic imaging and biopsy was evaluated at the facility where screening was performed on the basis of facility surveys and documented examinations. Designation of available standard-of-care diagnostic imaging required both digital mammography and breast US to be available at the screening facility, whereas standard-of-care biopsy availability indicated that both stereotactic and US-guided biopsy were available at the screening facility. Diagnostic DBT, breast MRI, DBT-guided biopsy, and MRI-guided biopsy were considered advanced modalities. Diagnostic imaging and biopsy performed within 90 days of abnormal screening mammography at screening facilities with on-site technology availability was evaluated. The technologies assessed were the same as previously mentioned, except the definition of standard of care allowed for examination with either technology rather than both. Additionally, DBT-guided biopsy was not included because of limited examination-level information on DBT guidance. Whether any same-day diagnostic service (ie, digital mammography, US, DBT, or stereotactic or US-guided biopsy) was performed after abnormal screening mammography at facilities with on-site availability of any of these services and whether same-day stereotactic or US-guided biopsy was performed after an abnormal diagnostic mammographic or US examination performed at facilities with on-site availability were evaluated.
Statistical Analysis
Descriptive statistics were used to summarize the characteristics of individuals, their screening mammography, facility availability of diagnostic services, and facility volume of same-day services. Sequential modified Poisson regression models were fit to identify factors associated with on-site availability and patients undergoing standard-of-care and advanced diagnostic imaging and same-day services. Modified Poisson regression estimates variances empirically to obtain valid estimates for binary outcomes without assuming that those outcomes follow a Poisson distribution and has been shown to be a valid alternative to log-binomial regression for binary outcome data (17). For each outcome, five sequential models were estimated for each sociodemographic factor of interest: race and ethnicity, neighborhood-level high school educational attainment, median household income, and residential rurality. Model 1 was unadjusted and included only the sociodemographic factor of interest, model 2 was adjusted for nonmodifiable or not easily modifiable individual-level factors, model 3 was additionally adjusted for modifiable individual-level factors and neighborhood-level factors, model 4 was additionally adjusted for health care system–level factors, and model 5 was additionally adjusted for the imaging registry to account for potential regional practice variations. The selected model ordering reflects the impact of sequentially adjusting for factors at progressive levels of influence in the multilevel-disparities framework (14,18). Models 2–5 were adjusted for examination year as a continuous linear covariate to account for changes in practice patterns over time. The 95% CIs for relative risks (RRs) were estimated using generalized estimating equations with robust standard errors, assuming a working independence covariance structure to account for clustering within screening facilities for models evaluating the on-site availability of diagnostic technologies or clustering within individuals for models evaluating the receipt of diagnostic technologies (19–21). Statistical analyses were performed (W.Z., with 15 years of experience) by using software (SAS, version 9.4; SAS Institute). Two-sided P < .05 indicated statistical significance.
Results
Patient, Examination, and Facility Characteristics
The study included 3 519 502 screening mammographic examinations performed in 1 123 177 female patients (median age, 59 years; IQR, 51–67 years). Examinations were from individuals who self-identified as Asian (10.3%; 362 440 of 3 519 502), Black (12.7%; 447 777 of 3 519 502), Hispanic or Latinx (6.5%; 227 177 of 3 519 502), White (68.3%; 2 403 159 of 3 519 502), or all other races and ethnicities (2.2%; 78 949 of 3 519 502) (Table 1). A total of 327 199 (9.3%) screening examinations were abnormal and 265 309 eligible examinations were included in analyses of diagnostic imaging, biopsy, and same-day diagnostic services performed. A total of 17 772 abnormal diagnostic mammographic and US examinations were included in the same-day biopsy analysis (Figure).
Table 1:
Study Sample of Screening Mammography
Flowchart of study examination selection and outcomes assessed. Alternate horizontal shading is used to highlight the sample of examinations that corresponds with the outcomes of interest. DBT = digital breast tomosynthesis.
Among the facilities included in the analyses of diagnostic services performed, 66.0% (68 of 103) provided same-day diagnostic services, with 8.7% (nine of 103) of facilities conducting at least 5% of their diagnostic services on the same day as the abnormal screening. Among the facilities included in the same-day biopsy analysis, 84% (27 of 32) provided same-day biopsy services, with 34% (11 of 32) of facilities conducting at least 5% of biopsies on the same day as an abnormal diagnostic evaluation. Additional details about patient, examination, and facility characteristics are available in Tables 1 and S1.
On-site Availability of Diagnostic and Imaging-guided Biopsy Services
In general, the RRs of on-site availability of standard-of-care or advanced diagnostic imaging or biopsy did not vary substantially across racial and ethnic groups in fully adjusted models (Table 2) or across sequential models (Appendix S1, Tables S2–S7). However, Asian patients were more likely to have on-site access to standard-of-care diagnostic imaging (RR, 1.10 [95% CI: 1.01, 1.21]; P = .04; Asian patients: 321 040 of 362 440 [88.6%]; White patients: 1 891 776 of 2 403 159 [78.7%]), and those in the all other races and ethnicities group were more likely to have on-site access to standard-of-care biopsy services (RR, 1.13 [95% CI: 1.03, 1.24; P = .009]; all other races and ethnicities group: 51 217 of 78 231 [65.5%]; White patients: 1 408 874 of 2 371 797 [59.4%]) than White patients. On-site access to diagnostic imaging or biopsy did not vary by neighborhood-level educational attainment or income. Individuals’ residential rurality was also not associated with their on-site access to standard-of-care diagnostic imaging and biopsy after full model adjustment. However, after full model adjustment, individuals living in rural neighborhoods (243 963 of 581 670; 41.9%) were less likely to have diagnostic DBT available at their screening facility than those living in urban areas (1 185 825 of 2 937 832; 40.4%) (RR, 0.84; 95% CI: 0.74, 0.96; P = .01).
Table 2:
On-site Availability of Standard-of-Care and Advanced Diagnostic Technologies in Fully Adjusted Models
Receipt of Diagnostic and Imaging-guided Biopsy Services within 90 Days of Abnormal Screening
Compared with White patients, patients in racial or ethnic minority groups were less likely to undergo examinations with some diagnostic technologies within 90 days of abnormal screening (Tables 3, S8–S12). For example, after full adjustment, Asian patients (RR, 0.95 [95% CI: 0.92, 0.98]; P < .001; 2361 of 5862 [40.3%]) and Black patients (RR, 0.92 [95% CI: 0.90, 0.94]; P < .001; 6757 of 16 537 [40.9%]) were less likely to undergo diagnostic DBT than White patients (28 296 of 64 262; 44.0%). Compared with White patients (2496 of 99 549; 2.5%), Asian patients, Hispanic or Latinx patients, and patients in the all other races and ethnicities category were less likely to undergo diagnostic breast MRI after an abnormal screening mammographic examination (Asian patients: RR, 0.72 [95% CI: 0.62, 0.83]; P < .001; 197 of 11 819 [1.7%]; Hispanic or Latinx patients: RR, 0.71 [95% CI: 0.61, 0.83]; P < .001; 185 of 11 452 [1.6%]; all other races and ethnicities group: RR, 0.77 [95% CI: 0.60, 0.98]; P = .04; 65 of 3523 [1.8%]).
Table 3:
Receipt of Standard-of-Care and Advanced Diagnostic Services within 90 Days of Abnormal Screening Mammography in Fully Adjusted Models
Individuals living in neighborhoods with lower educational attainment (1770 of 12 833; 13.8%) were less likely to undergo a standard-of-care biopsy within 90 days of abnormal screening than those living in neighborhoods with higher educational attainment (23 380 of 152 227; 15.4%) (RR, 0.92; 95% CI: 0.88, 0.97; P = .003). Otherwise, neighborhood-level high school educational attainment was not associated with undergoing diagnostic imaging or biopsy in any fully adjusted model.
Compared with individuals living in the highest income neighborhoods, those living in the lowest income neighborhoods were less likely to undergo standard-of-care diagnostic imaging (RR, 0.95 [95% CI: 0.94, 0.96]; P < .001; lowest income: 36 248 of 47 724 [76.0%]; highest income: 35 983 of 41 500 [86.7%]) and diagnostic DBT (RR, 0.95 [95% CI: 0.93, 0.98]; P < .001; lowest income: 11 150 of 25 949 [43.0%]; highest income: 8682 of 18 914 [45.9%]) within 90 days of screening. However, individuals living in the lowest income neighborhoods were more likely to undergo MRI (RR, 1.20 [95% CI: 1.07, 1.35; P = .003]; lowest income: 793 of 36 217 [2.2%]; highest income: 814 of 37 244 [2.2%]). In the fully adjusted model, neighborhood-level income was not associated with MRI-guided breast biopsy being performed.
Residential rurality was not associated with the use of standard-of-care diagnostic technologies in the fully adjusted models but was associated with receipt of advanced services. According to the fully adjusted model, rural-dwelling individuals (555 of 19 633; 2.8%) were more than twice as likely to undergo diagnostic MRI (RR, 2.20; 95% CI: 1.90, 2.54; P < .001) than were individuals living in urban areas (2767 of 124 670; 2.2%). However, rural neighborhoods (12 of 18 359; 0.07%) were associated with a lower likelihood of undergoing MRI-guided biopsy compared with urban neighborhoods (313 of 109 829; 0.3%) (RR, 0.46; 95% CI: 0.22, 0.97; P = .04) in the fully adjusted model.
Same-Day Diagnostic Service
Overall, Asian, Black, and Hispanic or Latinx patients received fewer same-day diagnostic services after undergoing a screening mammography with abnormal results at facilities offering any diagnostic or biopsy services. For example, Black patients (340 of 29 550; 1.2%) were nearly half as likely as White patients (4793 of 159 513; 3.0%) to undergo same-day diagnostic evaluation after full adjustment (RR, 0.56; 95% CI: 0.49, 0.63; P < .001) (Tables 4, S13).
Table 4:
Same-Day Diagnostic Services after Abnormal Screening Mammography and Same-Day Biopsies after Abnormal Diagnostic Mammography or Sonography in Fully Adjusted Models
Residents in the lowest-income neighborhoods (1084 of 59 885; 1.8%) were 58% less likely to undergo same-day diagnostic evaluations (RR, 0.42; 95% CI: 0.38, 0.47; P < .001) than were those living in the highest income neighborhoods (1493 of 54 741; 2.7%). According to the fully adjusted models, rural residents (1521 of 36 348; 4.2%) were more likely to undergo same-day diagnostic services than urban residents (4157 of 197 684; 2.1%) (RR, 1.51; 95% CI: 1.39, 1.65; P < .001).
Same-Day Biopsy
In the fully adjusted model, Black patients (37 of 1282; 2.9%) were found to be less likely to undergo a same-day biopsy after a biopsy recommendation at a facility offering biopsy services (RR, 0.46; 95% CI: 0.33, 0.65; P < .001) (Table 4) than White patients (439 of 12 753; 3.4%). However, Hispanic or Latinx patients (61 of 853; 7.2%) were more likely to undergo a same-day biopsy than were White patients (RR, 1.42; 95% CI: 1.07, 1.89; P = .02).
Individuals living in middle-income neighborhoods (287 of 8829; 3.3%) were less likely to undergo same-day biopsy than were those living in the highest-income neighborhoods (164 of 4420; 3.7%) according to the fully adjusted model (RR, 0.72; 95% CI: 0.59, 0.87; P < .001). Neighborhood-level educational attainment and rurality were not associated with same-day biopsy in fully adjusted models.
Discussion
In this large retrospective study, we assessed the on-site availability and receipt of diagnostic breast imaging services after abnormal screening mammography. We found that in almost all fully adjusted models, the on-site availability of diagnostic breast imaging and breast biopsy services did not substantially vary on the basis of race and ethnicity or neighborhood-level socioeconomic factors. However, notable differences existed across sociodemographic groups in whether same-day diagnostic examinations were performed. Asian, Black, and Hispanic or Latinx patients (eg, Black patients: relative risk [RR], 0.56; 95% CI: 0.49, 0.63; P < .001) and those living in neighborhoods with a lower median income (RR, 0.42; 95% CI: 0.38, 0.47; P < .001) were less likely to receive same-day diagnostic services after abnormal screening mammography. This difference in receiving same-day diagnostic services persisted after adjustment for multilevel factors. Black individuals were also less likely to undergo a same-day biopsy after an abnormal diagnostic evaluation (RR, 0.46; 95% CI: 0.33, 0.65; P < .001).
Same-day diagnostic services reduce loss to follow-up, decrease the time to diagnostic resolution of abnormal imaging findings and the duration of patient anxiety while patients await results, and increase patient satisfaction (10,11,22,23). Offering same-day diagnostic services may also reduce disparities in timely diagnosis after abnormal screening mammography (10,11,24), but we found that availability of on-site diagnostic services has not ensured the receipt of same-day services at similar rates across sociodemographic groups. The number of same-day examinations performed was low, and it is not known whether the facilities included in our analysis offered same-day diagnostic services on an ad hoc basis or through a formal program. Additionally, it is not known whether differences in receiving same-day services reflect patient preferences or other factors. The finding that rural individuals receive more same-day services suggests that services may be targeted to patients with clear barriers, such as long travel times. However, the observed racial and ethnic differences in receiving same-day diagnostic services are consistent with the racial disparities observed before the implementation of a comprehensive same-day diagnostic services program at a large, major academic institution (10,11). When same-day diagnostic services are offered, additional interventions may be necessary to ensure that barriers to receiving such services are identified and addressed.
Our observations of few disparities in the on-site availability of diagnostic services are consistent with earlier studies. For example, Lee et al (9) concluded that the availability of DBT screening was not substantially different across racial and ethnic groups after the initial diffusion phase. A separate study by Lee et al (25) indicated that the availability of diagnostic US and biopsy did not vary depending on the patient population served by the imaging facility. Although it is unclear which facilities routinely offer same-day biopsy services and the sociodemographics of the population served at such facilities, our findings provide additional evidence that the availability of diagnostic services at the individual’s screening facility is not a contributing factor to differences in the receipt of same-day diagnostic services and the subsequent immediate resolution of abnormal screening findings.
Our study has several strengths. First, our study included more than 3 million screening mammographic examinations from a national sample of 136 facilities. Our study expands on previous studies by evaluating the full range of imaging modalities that can inform diagnosis after abnormal screening mammography, including same-day services, which could be used to inform efforts aimed at reducing disparities in timely diagnosis. Expanding our understanding of on-site availability and receipt of breast imaging services after screening mammography is important in evaluating breast imaging outcomes and potential disparities across the entire episode of care (26).
Our study had several limitations. First, although the included examinations were conducted at facilities across six states, the study population may have been more educated and less rural than the national population. Second, variables that may have impacted individuals’ attendance at a facility or receipt of available diagnostic services were not included in these analyses (eg, insurance status, employment, transportation barriers or travel time, childcare needs, updated linkage with neighborhood-level data, and body mass index). Third, we excluded 11.5% (489 599 of 4 266 919) of the examinations because of missing data; however, sensitivity analyses including “missing” as a category demonstrated similar results, suggesting that our results were not substantially biased. Fourth, it is unknown whether individuals declined the opportunity for same-day services or were not offered such services. Studies assessing patient preferences for same-day services are needed to address this knowledge gap. Fifth, the ability of patients to obtain diagnostic services outside the studied registries may have led to inadequate capture of some diagnostic service use data, such as MRI-guided biopsy. Sixth, whereas some facility-level characteristics were available for analysis, information regarding potential service availability changes over time, and how facilities use same-day services was unavailable. Finally, breast cancer outcomes are beyond the scope of the present study but will be included in future analyses.
In conclusion, in this large retrospective study, we did not detect major differences in the on-site availability of most diagnostic services across different groups of individuals on the basis of race and ethnicity or neighborhood-level socioeconomic factors but observed differences in the receipt of standard-of-care diagnostic services, advanced technologies, same-day diagnostic services, and same-day biopsies across different groups. These differences may lead to disparities in the timely diagnosis of breast cancer on the basis of race and ethnicity and socioeconomic status. Future studies evaluating the associations between on-site availability and the receipt of diagnostic services, the time to diagnostic resolution of imaging abnormalities, and the time to definitive surgery and treatment are needed.
Acknowledgments
Acknowledgments
We thank the patients, mammography facilities, and radiologists for the data they have provided for this study. Information about the Breast Cancer Surveillance Consortium may be found at http://www.bcsc-research.org/.
Study supported by the National Cancer Institute (R01CA266377). Data collection for this research was additionally supported by the Breast Cancer Surveillance Consortium with funding from the National Cancer Institute (P01CA154292). Cancer and vital status data collection was supported by several state public health departments and cancer registries (http://www.bcsc-research.org/work/acknowledgement.html). M.B.L. supported in part by the Association of Academic Radiology Clinical Effectiveness in Radiology Research Academic Fellowship Award, B.L.S. supported by the National Institute of General Medical Sciences (U54GM115516), and E.J.A.B. supported by the National Cancer Institute (R50CA211115). All statements in this work, including its findings and conclusions, are solely those of the authors and do not necessarily represent the views of the National Cancer Institute or the National Institutes of Health.
1Current address: Department of Biostatistics, Brown University School of Public Health, Providence, RI.
Disclosures of conflicts of interest: M.B.L. Salary support paid to institution from GE HealthCare, Association of Academic Radiology; support for attending meetings and/or travel from GE HealthCare. W.Z. No relevant relationships. D.L.M. Grants to institution from American Cancer Society, PCORI; royalties from Elsevier. T.O. Funding to institution from National Cancer Institute. L.M.H. No relevant relationships. G.H.R. No relevant relationships. K.K. No relevant relationships. B.L.S. Grants to institution from American Cancer Society, American College of Radiology, PCORI. E.J.A.B. No relevant relationships. E.S.O. No relevant relationships. A.N.A.T. No relevant relationships. R.M.d.A. No relevant relationships. R.A.H. Grants to institution from FDA, VA, PCORI. J.M.L. Grant from GE HealthCare. C.I.L. Royalties from UpToDate, Oxford University Press, McGraw Hill; consulting fees from DeepHealth/RadNet; deputy editor, Journal of the American College of Radiology.
Abbreviations:
- DBT
- digital breast tomosynthesis
- RR
- relative risk
References
- 1. Caswell-Jin JL , Sun LP , Munoz D , et al . Analysis of Breast Cancer Mortality in the US-1975 to 2019 . JAMA 2024. ; 331 ( 3 ): 233 – 241 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Hubbard RA , Zhu W , Horblyuk R , et al . Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography . Breast Cancer Res Treat 2013. ; 138 ( 3 ): 879 – 887 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Alsheik NH , Dabbous F , Pohlman SK , et al . Comparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health System . Acad Radiol 2019. ; 26 ( 5 ): 597 – 605 . [DOI] [PubMed] [Google Scholar]
- 4. Lee CI , Bogart A , Hubbard RA , et al . Advanced Breast Imaging Availability by Screening Facility Characteristics . Acad Radiol 2015. ; 22 ( 7 ): 846 – 852 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Bazzi T , Al-Husseini M , Saravolatz L , Kafri Z . Trends in Breast Cancer Incidence and Mortality in the United States From 2004-2018: A Surveillance, Epidemiology, and End Results (SEER)-Based Study . Cureus 2023. ; 15 ( 4 ): e37982 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Lewis-Thames MW , Langston ME , Khan S , et al . Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER) . JAMA Netw Open 2022. ; 5 ( 5 ): e2212246 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Goel N , Westrick AC , Bailey ZD , et al . Structural Racism and Breast Cancer-specific Survival: Impact of Economic and Racial Residential Segregation . Ann Surg 2022. ; 275 ( 4 ): 776 – 783 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Wiese D , Stroup AM , Islami F , et al . Geographic diffusion of digital mammography in the United States . Cancer 2023. ; 129 ( 14 ): 2144 – 2151 . [DOI] [PubMed] [Google Scholar]
- 9. Lee CI , Zhu W , Onega T , et al . Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women’s Race/Ethnicity and Socioeconomic Status . JAMA Netw Open 2021. ; 4 ( 2 ): e2037546 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Dontchos BN , Achibiri J , Mercaldo SF , et al . Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic . AJR Am J Roentgenol 2022. ; 218 ( 2 ): 270 – 278 . [DOI] [PubMed] [Google Scholar]
- 11. Dontchos BN , Narayan AK , Seidler M , et al . Impact of a Same-Day Breast Biopsy Program on Disparities in Time to Biopsy . J Am Coll Radiol 2019. ; 16 ( 11 ): 1554 – 1560 . [DOI] [PubMed] [Google Scholar]
- 12. D’Orsi CJ , Sickles EA , Mendelson EB , et al . ACR BI-RADS Atlas: Breast Imaging Reporting and Data System . 5th ed. American College of Radiology; , 2013. . [Google Scholar]
- 13. von Elm E , Altman DG , Egger M , Pocock SJ , Gøtzsche PC , Vandenbroucke JP ; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies . J Clin Epidemiol 2008. ; 61 ( 4 ): 344 – 349 . [DOI] [PubMed] [Google Scholar]
- 14. U.S. Census Bureau . EDUCATIONAL ATTAINMENT . American Community Survey, ACS 5-Year Estimates Subject Tables, Table S1501 , 2011. . https://data.census.gov/table/ACSST5Y2011.S1501 .
- 15. U.S. Census Bureau . MEDIAN INCOME IN THE PAST 12 MONTHS (IN 2011 INFLATION-ADJUSTED DOLLARS) . American Community Survey, ACS 5-Year Estimates Subject Tables, Table S1903 , 2011. . https://data.census.gov/table/ACSST5Y2011.S1903 .
- 16. United States Department of Agriculture Economic Research Service . Rural-Urban Commuting Area Codes . Economic Research Service , United States: Department of Agriculture; . https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes/documentation/. Updated September 25, 2023. Accessed October 12, 2023 . [Google Scholar]
- 17. Yelland LN , Salter AB , Ryan P . Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data . Am J Epidemiol 2011. ; 174 ( 8 ): 984 – 992 . [DOI] [PubMed] [Google Scholar]
- 18. Lawson MB , Scheel JR , Onega T , Carlos RC , Lee CI . Tackling Health Disparities in Radiology: A Practical Conceptual Framework . J Am Coll Radiol 2022. ; 19 ( 2 2 Pt B ): 344 – 347 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Liang K-Y , Zeger SL . Longitudinal data analysis using generalized linear models . Biometrika 1986. ; 73 ( 1 ): 13 – 22 . [Google Scholar]
- 20. Liang KY , Zeger SL . Regression analysis for correlated data . Annu Rev Public Health 1993. ; 14 ( 1 ): 43 – 68 . [DOI] [PubMed] [Google Scholar]
- 21. Pepe MS , Anderson GL . A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data . Commun Stat Simul Comput 1994. ; 23 ( 4 ): 939 – 951 . [Google Scholar]
- 22. Lindfors KK , O’Connor J , Parker RA . False-positive screening mammograms: effect of immediate versus later work-up on patient stress . Radiology 2001. ; 218 ( 1 ): 247 – 253 . [DOI] [PubMed] [Google Scholar]
- 23. Wilson TE , Wallace C , Roubidoux MA , Sonnad SS , Crowe DJ , Helvie MA . Patient satisfaction with screening mammography: online vs off-line interpretation . Acad Radiol 1998. ; 5 ( 11 ): 771 – 778 . [DOI] [PubMed] [Google Scholar]
- 24. Oluyemi E . Editorial Comment: Offering Immediate Screening Mammography Interpretation May Be an Effective Way to Reduce the Racial and Ethnic Disparity Gap in the Time to Diagnostic Follow-Up . AJR Am J Roentgenol 2022. ; 218 ( 2 ): 278 . [DOI] [PubMed] [Google Scholar]
- 25. Lee CI , Bogart A , Germino JC , et al . Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations . J Med Screen 2016. ; 23 ( 1 ): 24 – 30 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Sprague BL , Miglioretti DL , Lee CI , Perry H , Tosteson AAN , Kerlikowske K . New mammography screening performance metrics based on the entire screening episode . Cancer 2020. ; 126 ( 14 ): 3289 – 3296 . [DOI] [PMC free article] [PubMed] [Google Scholar]






